School of Computer Science and Technology, Harbin Institute of Technology, Harbin, China.
Beidahuang Industry Group General Hospital, Harbin, China.
Aging Cell. 2024 Nov;23(11):e14271. doi: 10.1111/acel.14271. Epub 2024 Sep 19.
The causative mechanisms underlying the genetic relationships of neurodegenerative diseases with epigenetic aging and human longevity remain obscure. We aimed to detect causal associations and shared genetic etiology of neurodegenerative diseases with epigenetic aging and human longevity. We obtained large-scale genome-wide association study summary statistics data for four measures of epigenetic age (GrimAge, PhenoAge, IEAA, and HannumAge) (N = 34,710), multivariate longevity (healthspan, lifespan, and exceptional longevity) (N = 1,349,462), and for multiple neurodegenerative diseases (N = 6618-482,730), including Lewy body dementia, Alzheimer's disease (AD), Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis. Main analyses were conducted using multiplicative random effects inverse-variance weighted Mendelian randomization (MR), and conditional/conjunctional false discovery rate (cond/conjFDR) approach. Shared genomic loci were functionally characterized to gain biological understanding. Evidence showed that AD patients had 0.309 year less in exceptional longevity (IVW beta = -0.309, 95% CI: -0.38 to -0.24, p = 1.51E-19). We also observed suggestively significant causal evidence between AD and GrimAge age acceleration (IVW beta = -0.10, 95% CI: -0.188 to -0.013, p = 0.02). Following the discovery of polygenic overlap, we identified rs78143120 as shared genomic locus between AD and GrimAge age acceleration, and rs12691088 between AD and exceptional longevity. Among these loci, rs78143120 was novel for AD. In conclusion, we observed that only AD had causal effects on epigenetic aging and human longevity, while other neurodegenerative diseases did not. The genetic overlap between them, with mixed effect directions, suggested complex shared genetic etiology and molecular mechanisms.
神经退行性疾病与表观遗传衰老和人类长寿的遗传关系的因果机制尚不清楚。我们旨在检测神经退行性疾病与表观遗传衰老和人类长寿的因果关联和共同遗传病因。我们获得了大规模全基因组关联研究的四个表观遗传年龄(GrimAge、PhenoAge、IEAA 和 HannumAge)(N=34710)、多变量长寿(健康寿命、寿命和超长寿命)(N=1349462)和多种神经退行性疾病(N=6618-482730)的汇总统计数据,包括路易体痴呆、阿尔茨海默病(AD)、帕金森病、肌萎缩侧索硬化症和多发性硬化症。主要分析使用乘法随机效应逆方差加权孟德尔随机化(MR)和条件/联合虚假发现率(cond/conjFDR)方法进行。共享基因组座被功能表征以获得生物学理解。证据表明,AD 患者的超长寿命减少了 0.309 年(IVW beta=-0.309,95%CI:-0.38 至-0.24,p=1.51E-19)。我们还观察到 AD 与 GrimAge 年龄加速之间存在暗示性显著的因果证据(IVW beta=-0.10,95%CI:-0.188 至-0.013,p=0.02)。在发现多基因重叠后,我们确定了 AD 和 GrimAge 年龄加速之间的共享基因组座 rs78143120,以及 AD 和超长寿命之间的 rs12691088。在这些基因座中,rs78143120 是 AD 的新基因座。总之,我们观察到只有 AD 对表观遗传衰老和人类长寿有因果影响,而其他神经退行性疾病则没有。它们之间的遗传重叠,具有混合的效应方向,表明存在复杂的共同遗传病因和分子机制。